Medica Group has agreed to acquire Axon Diagnostics in a deal it says will expand access to high-quality remote diagnostic reporting across the NHS and the independent healthcare sector.
The transaction also includes Axon’s sister company, MITIS Health, whose Clinical Desktop technology supports high-fidelity remote reporting valued by many NHS trusts and Axon clients.
The combined group will offer what the companies describe as the UK’s largest clinical reporting network, covering major diagnostic subspecialties and providing capacity for routine and urgent cases, including during periods of surge demand. Medica said the enlarged business will serve more than 2.5 million patients across 55 per cent of NHS trusts.
Andrew Cannon, chief executive of Medica Group, said: “This merger marks a significant milestone for Medica. Bringing Axon into Medica strengthens our position as the UK’s leading diagnostics provider.”
Rahul Mehta, chief executive of Axon Diagnostics, said: “This merger combines our technology and agile approach with Medica’s scale and clinical excellence, meaning more patients will benefit from faster and smarter reporting.”
IK Partners acquired Medica Group in July 2023, delisting it from the London Stock Exchange.
